FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection solutions to reduce the spread of harmful pathogens, ...
Jessica Blavignac, Director of Scientific and Medical Affairs, bioMérieux Somewhere in Canada today, a patient will arrive at ...
RESPIRATORY viral infections are emerging as a potential driver of lung cancer development, with new findings suggesting that ...
Ambient air pollution is associated with respiratory infection burden in the first year of life, according to preliminary ...
A rise in lyme disease-positive ticks and an increase in emergency room visits due to bites this spring has sparked plenty of ...
Aedes aegypti, commonly known as the yellow fever mosquito, is a highly adapted, invasive mosquito species recognized as a ...
In Nepal, the H5N1 virus was first detected in 2009 on poultry farms in the eastern region. A decade later, the country ...
Company on track to initiate a randomized, double-blind, placebo-controlled, adaptive Phase 2 field study in the first half of 2027, pending FDA ...
Dar es Salaam. It is a relief for adolescent girls and young women who dropped out of formal education due to various challenges, including pregnancy, after the Doris Mollel Foundation rolled out ...
Insulin resistance is a common extrahepatic manifestation of hepatitis C virus (HCV) infection (HCVi), but its mechanism is ...
This World Immunisation Week and beyond, MSF teams share access and innovation advancements that, if achieved in the years to ...
Cardiovascular diseases (CVDs) remain the leading cause of death worldwide and are now increasingly recognized as conditions with a strong ...